Nuveen Asset Management, LLC

Holdings History for Protagonist Therapeutics, Inc - COM (PTGX)

Symbol: PTGX on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2024	0%	0%	$10.4M	232K	-141,918	-37.9%	$45.00	Q3 2024
6/30/2024	0%	0%	$13M	374K	-304,209	-44.9%	$34.65	Q2 2024
3/31/2024	0.01%	+0%	$19.6M	678K	+372,782	+122%	$28.93	Q1 2024
12/31/2023	0%	0%	$7M	305K	-230,605	-43%	$22.93	Q4 2023
9/30/2023	0%	0%	$8.94M	536K	-399,937	-42.7%	$16.68	Q3 2023
6/30/2023	0.01%	+0%	$25.9M	936K	+107,490	+13%	$27.62	Q2 2023
3/31/2023	0.01%	+0%	$19.1M	828K	+467,757	+130%	$23.00	Q1 2023
12/31/2022	0%	+0%	$3.94M	361K	+22,170	+6.55%	$10.91	Q4 2022
9/30/2022	0%	+0%	$2.85M	339K	+572	+0.17%	$8.43	Q3 2022
6/30/2022	0%		$2.67M	338K			$7.91	Q2 2022
3/31/2022			$2.35M	304K			$7.73^*	Q1 2022
12/31/2021			$1.85M	240K			$7.73^*	Q4 2021
9/30/2021			$1.26M	163K			$7.73^*	Q3 2021
6/30/2021			$1.29M	166K			$7.73^*	Q2 2021
3/31/2021			$1.12M	145K			$7.73^*	Q1 2021
12/31/2020			$870K	113K			$7.73^*	Q4 2020
9/30/2020			$876K	113K			$7.73^*	Q3 2020
6/30/2020			$701K	90.8K			$7.72^*	Q2 2020
3/31/2020	0%	0%	$700K	99.1K	-95,364	-49%	$7.07	Q1 2020
12/31/2019	0%	+0%	$1.37M	194K	+43,906	+29.2%	$7.05	Q4 2019
9/30/2019	0%	+0%	$1.81M	151K	+111,656	+287%	$12.01	Q3 2019
6/30/2019	0%	+0%	$470K	38.9K	+38,875	NEW	$12.09	Q2 2019

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.